Aptevo Therapeutics Inc.APVONASDAQ
Loading
Year-over-year book value per share growth
Latest
-51.40%
↓ 257% vs avg
Percentile
P28
Within normal range
Streak
1 qtr
Consecutive declineDecelerating
Average
-14.38%
Historical baseline
| Period | Value |
|---|---|
| Q3 2025 | -51.40% |
| Q2 2025 | 143.75% |
| Q1 2025 | -130.98% |
| Q4 2024 | -78.97% |
| Q3 2024 | -66.95% |
| Q2 2024 | -85.73% |
| Q1 2024 | -67.82% |
| Q4 2023 | -46.35% |
| Q3 2023 | -53.34% |
| Q2 2023 | -24.29% |
| Q1 2023 | 19.14% |
| Q4 2022 | -10.23% |
| Q3 2022 | -32.51% |
| Q2 2022 | 484.99% |
| Q1 2022 | -580.03% |
| Q4 2021 | -83.35% |
| Q3 2021 | -51.28% |
| Q2 2021 | 28.71% |
| Q1 2021 | -41.25% |
| Q4 2020 | 494.10% |
| Q3 2020 | -74.54% |
| Q2 2020 | -42.25% |
| Q1 2020 | 0.00% |
| Q4 2019 | -100.00% |
| Q3 2019 | -24.76% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |
| Q4 2018 | 0.00% |
| Q3 2018 | 0.00% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |
| Q4 2017 | 0.00% |
| Q3 2017 | 0.00% |
| Q2 2017 | 0.00% |
| Q1 2017 | 0.00% |
| Q4 2016 | 0.00% |
| Q3 2016 | 0.00% |
| Q2 2016 | 0.00% |
| Q1 2016 | -100.00% |
| Q4 2015 | 0.00% |